India Coalesces Innovation and Evidence in Cancer Care

Medtech startups and healthcare innovations are revolutionizing India’s approach to cancer prevention and early detection. By raising awareness, encouraging timely action, and making screenings more accessible and affordable, they are driving meaningful change. India pairs these efforts with world-class, cost-effective treatment, leveraging robotic surgery and advanced radiation therapies to enhance precision, minimize complications, and accelerate recovery.

While breakthroughs such as cancer vaccines and immunotherapies hold tremendous promise, they require rigorous clinical validation, warranting cautious optimism. Cervical cancer vaccination, for instance, is most effective before the onset of sexual activity, and age-specific protocols ensure broad protection. Together, innovation, evidence-based care, and proactive prevention are reshaping India’s cancer landscape.

In an exclusive discussion with The Interview World at Healthcare Horizon 2025, hosted by Mediways Foundation and OSVI Healthcare, Dr. Sudipto De, Consultant in Surgical Oncology and Robotic Surgery at Metro Hospitals, highlighted the pivotal role of medtech startups and healthcare innovations in preventing and detecting cancer early. He emphasized the evolving Indian healthcare ecosystem and shared his perspectives on Russia’s recent announcement of a cancer vaccine. Additionally, Dr. De offered insights into the effectiveness of the cervical cancer vaccine. Here are the key takeaways from his illuminating conversation.

Q: How are medtech startups and innovations contributing to the prevention and early detection of cancer?

A: Medtech and healthcare startups are poised to play a decisive role in transforming India’s fight against cancer. They are not only driving widespread awareness but also working to reduce the incidence of advanced-stage disease. By harnessing the power of social media, these innovators are breaking down barriers of knowledge and making people truly understand the importance of early action. At the same time, they are building groundbreaking solutions that make cancer screening programs more accessible, affordable, and inclusive. Together, these efforts signal the next revolution in Indian healthcare, a movement powered by startups and the broader health-tech industry, one that promises to be both disruptive and deeply impactful.

Q: How is India’s healthcare ecosystem evolving to support faster patient recovery, and where does India stand globally in treatment?

A: India today holds a uniquely powerful position in global healthcare. We deliver world-class treatment at some of the most affordable prices in the world. While concerns about overpricing occasionally surface, the reality becomes clear when we compare costs with Western nations or even advanced Asian economies like Singapore, Japan, or China. At a fraction of their prices, India provides the same, often superior, quality of care.

This excellence is rooted in the rigorous training offered by our leading hospitals and medical institutions. Beyond that, the healthcare industry itself continues to invest heavily, creating systems designed to deliver treatment with fewer complications and better outcomes. Robotic surgery now enhances precision in complex operations, while advanced radiation therapies minimize side effects and improve patient recovery. Together, these innovations underscore how India combines affordability with cutting-edge care, strengthening its role as a true global healthcare leader.

Q: With Russia announcing a cancer vaccine, what future do you foresee for such solutions in cancer prevention and treatment?

A: What many people fail to recognize is that every new treatment or breakthrough must be validated through rigorous clinical trials. India already has a vaccine against cervical cancer, yet the real challenge lies in implementation, spreading awareness, building trust, and helping people understand how vaccination and early detection can dramatically reduce the disease. The results are visible: once one of the country’s most prevalent cancers, cervical cancer has now fallen below breast cancer in incidence across many regions.

At the same time, headlines often exaggerate unproven advances. For instance, a recent report hailed immunotherapy as a “magical cure” for rectal cancer. However, such claims remain unsubstantiated, as they stem from studies involving fewer than ten patients. The medical community still awaits large-scale trials with thousands of participants before drawing definitive conclusions.

Therefore, while we must approach sensational news with caution, we cannot ignore the promise of innovation. The path forward is clear: embrace progress, but ground it firmly in evidence.

Q: Is the cervical cancer vaccine only effective for individuals under 20, or does it remain beneficial after that age?

A: The key point is that the vaccine is most effective before your first sexual intercourse, not strictly before the age of 20. Once intercourse has occurred, the likelihood of HPV infection, human papillomavirus, which spreads primarily through sexual contact, already increases. While the vaccine may still provide some benefit afterward, its protective effect is significantly reduced once exposure has happened.

Therefore, the ideal time for vaccination is any time before sexual activity begins. In clinical practice, however, doctors generally do not ask every patient about their sexual history directly. To address this sensitively, we follow an age-based vaccination protocol, which ensures broad protection without needing to discuss intimate details openly.